https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Thu, 26 Aug 2021 16:13:58 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/ayc2faoivk-the-impact-of-covid-19-on-validating-cell-therapy-products/ Thu, 13 May 2021 14:20:38 +0000 http://13.40.107.223/video/ayc2faoivk-the-impact-of-covid-19-on-validating-cell-therapy-products/ Bruce Levine, PhD, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, discusses the impact of COVID-19 on validating cell therapy products. Despite mesenchymal stromal cells having been established as a cell-based therapy for acute respiratory distress syndrome (ARDS), they have yet to be specifically utilized in viral respiratory infections. Dr. Levine also evaluates the recent influx of research on this topic, urging caution as well as stressing patient safety and scientific rationale when creating new proposals. This interview took place during the ESMO TAT 2021 conference.

]]> https://mirror.vjregenmed.com/video/ws86r1hn3li-what-to-expect-at-isct-2021/ Thu, 13 May 2021 14:20:37 +0000 http://13.40.107.223/video/ws86r1hn3li-what-to-expect-at-isct-2021/ Bruce Levine, PhD, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, discusses future sessions at the International Society Cell & Gene Therapy Annual Meeting in New Orleans, LA, of which includes plenary sessions on mesenchymal stromal cells, COVID-19 trials, regulatory oversight, first in man exosome trials, and the applications of CAR-T/NK cells. This interview took place during the ESMO TAT 2021 conference.

]]>